Key manufactured products that enable developers to build healthier homes
Post-money valuation โ
$45.2M
As of Feb 2023 ยท from Green Canopy NODE Preferred Stock 1 ยท pre-money + amount raised, not a traded price
Total raised
$109,294
Across 1 round since 2022
Latest share price
$92.87
Green Canopy NODE Preferred Stock 1 offering price
Financials
FY2020โFY2025 ยท from SEC filings ยท hover any figure for its source
$24.9M
โ$5.6M
2020
$14.5M
โ$1.7M
2021
$14.5M
โ$6.3M
2022
$12.8M
โ$3.8M
2024
$14.7M
โ$1.9M
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2024
FY2025
Income statement
Revenue
$24,853,800
$14,537,278
$14,482,173
$12,849,158
$14,738,979
Cost of goods sold
$26,343,806
$12,630,638
$14,638,655
$11,339,731
$13,352,968
Gross margin
-6%
13%
-1%
12%
9%
Net income
-$5,574,124
-$1,714,618
-$6,252,022
-$3,795,354
-$1,894,553
Taxes paid
$0
$72,744
$115,172
$0
$0
Balance sheet
Cash
$1,043,183
$5,990,250
$1,184,956
$588,479
$271,929
Accounts receivable
$678,560
$3,774,799
$1,185,937
$0
$41,956,506
Total assets
$4,354,825
$10,237,826
$3,628,368
$40,010,534
$42,761,374
Short-term debt
$7,578,914
$750,000
$591,660
$750,000
$1,225,319
Long-term debt
$533,220
$110,000
$0
$0
$4,685,000
Total liabilities
$8,112,134
$860,000
$591,660
$750,000
$5,910,319
Other
Headcount
โ
45
45
โ
45
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.